Anja Klein1, Andreas Baranowski2, Ulrike Ritz1, Christiane Mack1, Hermann Götz3, Eva Langendorf1, Bilal Al-Nawas4, Philipp Drees1, Pol M Rommens1, Alexander Hofmann1,5. 1. Department of Orthopaedics and Traumatology, Biomatics Group, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany. 2. Department of Orthopaedics and Traumatology, Biomatics Group, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany. andreas.baranowski@unimedizin-mainz.de. 3. Platform for Biomaterial Research, Biomatics Group, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany. 4. Department of Oral and Maxillofacial Surgery, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany. 5. Department of Traumatology and Orthopaedics 1, Westpfalz-Medical Centre Kaiserslautern, Kaiserslautern, Germany.
Abstract
PURPOSE: In orthopedic and trauma surgery, calcium phosphate cement (CPC) scaffolds are widely used as substitute for autologous bone grafts. The purpose of this study was to evaluate bone formation in a femoral condyle defect model in rats after scaffold-coating with bioactive bone sialoprotein (BSP). Our hypothesis was that BSP-coating results in additional bone formation. METHODS: In 20 Wistar rats, defects of 3.0 mm diameter were drilled into the lateral femoral condyles of both legs. BSP-coated scaffolds or uncoated control scaffolds were implanted into the defects. After 4 and 8 weeks, five rats of each group were euthanized, respectively. µCT scans and histological analyses were performed. The ratio of bone volume-total volume (BV/TV) was analyzed and histological sections were evaluated. RESULTS: At week four, bone fraction reached 5.2 ± 1.7% in BSP-coated scaffolds and 4.5 ± 3.2% in the control (p = 0.06). While bone fraction of the BSP-group did not change much between week four and eight [week eight: 5.4 ± 3.8% (p = 0.53)], there was a tendency towards an increase in the control [week eight: 7.0 ± 2.2% (p = 0.08)]. No significant difference in bone fraction were observable between BSP-coated and uncoated scaffolds at week eight (p = 0.08). CONCLUSIONS: A significant superiority of BSP-coated scaffolds over uncoated scaffolds could not be proven. However, BSP-coating showed a tendency towards improving bone ingrowth in the scaffolds 4 weeks after implantation. This effect was only short-lived: bone growth in the control scaffolds tended to outpace that of the BSP-group at week eight.
PURPOSE: In orthopedic and trauma surgery, calcium phosphate cement (CPC) scaffolds are widely used as substitute for autologous bone grafts. The purpose of this study was to evaluate bone formation in a femoral condyle defect model in rats after scaffold-coating with bioactive bone sialoprotein (BSP). Our hypothesis was that BSP-coating results in additional bone formation. METHODS: In 20 Wistar rats, defects of 3.0 mm diameter were drilled into the lateral femoral condyles of both legs. BSP-coated scaffolds or uncoated control scaffolds were implanted into the defects. After 4 and 8 weeks, five rats of each group were euthanized, respectively. µCT scans and histological analyses were performed. The ratio of bone volume-total volume (BV/TV) was analyzed and histological sections were evaluated. RESULTS: At week four, bone fraction reached 5.2 ± 1.7% in BSP-coated scaffolds and 4.5 ± 3.2% in the control (p = 0.06). While bone fraction of the BSP-group did not change much between week four and eight [week eight: 5.4 ± 3.8% (p = 0.53)], there was a tendency towards an increase in the control [week eight: 7.0 ± 2.2% (p = 0.08)]. No significant difference in bone fraction were observable between BSP-coated and uncoated scaffolds at week eight (p = 0.08). CONCLUSIONS: A significant superiority of BSP-coated scaffolds over uncoated scaffolds could not be proven. However, BSP-coating showed a tendency towards improving bone ingrowth in the scaffolds 4 weeks after implantation. This effect was only short-lived: bone growth in the control scaffolds tended to outpace that of the BSP-group at week eight.
Entities:
Keywords:
Bone healing; Bone sialoprotein; Calcium phosphate cement scaffold; Rat model; Three-dimensional plotting
Authors: Anthony C Jones; Christoph H Arns; Dietmar W Hutmacher; Bruce K Milthorpe; Adrian P Sheppard; Mark A Knackstedt Journal: Biomaterials Date: 2008-12-16 Impact factor: 12.479
Authors: Jonathan Bernhard; James Ferguson; Bernhard Rieder; Patrick Heimel; Thomas Nau; Stefan Tangl; Heinz Redl; Gordana Vunjak-Novakovic Journal: Biomaterials Date: 2017-05-31 Impact factor: 12.479
Authors: Hajar Seyednejad; Debby Gawlitta; Raoul V Kuiper; Alain de Bruin; Cornelus F van Nostrum; Tina Vermonden; Wouter J A Dhert; Wim E Hennink Journal: Biomaterials Date: 2012-03-20 Impact factor: 12.479
Authors: Anja Lode; Katrin Meissner; Yongxiang Luo; Frank Sonntag; Stefan Glorius; Berthold Nies; Corina Vater; Florian Despang; Thomas Hanke; Michael Gelinsky Journal: J Tissue Eng Regen Med Date: 2012-08-30 Impact factor: 3.963
Authors: Mahrokh Dadsetan; Teja Guda; M Brett Runge; Dindo Mijares; Racquel Z LeGeros; John P LeGeros; David T Silliman; Lichun Lu; Joseph C Wenke; Pamela R Brown Baer; Michael J Yaszemski Journal: Acta Biomater Date: 2015-01-07 Impact factor: 8.947
Authors: Caroline Seebach; Dirk Henrich; Christopher Kähling; Kerstin Wilhelm; Andrea E Tami; Mauro Alini; Ingo Marzi Journal: Tissue Eng Part A Date: 2010-06 Impact factor: 3.845
Authors: Stefan Schaeren; Claude Jaquiéry; Francine Wolf; Adam Papadimitropoulos; Andrea Barbero; Elke Schultz-Thater; Michael Heberer; Ivan Martin Journal: J Biomed Mater Res A Date: 2010-03-15 Impact factor: 4.396
Authors: Anja Kriegel; Christian Schlosser; Tanja Habeck; Christoph Dahmen; Hermann Götz; Franziska Clauder; Franz Paul Armbruster; Andreas Baranowski; Philipp Drees; Pol Maria Rommens; Ulrike Ritz Journal: Int J Bioprint Date: 2022-07-12